Javad Shahidi
Keine laufenden Positionen mehr
Vermögen: 1 Mio $ am 30.04.2024
Profil
Javad Shahidi worked as Vice President-Global Research & Development at Daiichi Sankyo, Inc. from 2019 to 2022.
He also worked as Chief Medical Officer at Centessa Pharmaceuticals Plc in 2022.
Prior to his professional experience, he earned a graduate degree from McGill University and a doctorate degree from Shahid Beheshti University of Medical Sciences.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.10.2022 | 158 932 ( 0,18% ) | 1 Mio $ | 30.04.2024 |
Ehemalige bekannte Positionen von Javad Shahidi
| Unternehmen | Position | Ende |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Technik-/Wissenschafts-/F&E-Leiter | 14.10.2022 |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2022 |
Ausbildung von Javad Shahidi
| McGill University | Graduate Degree |
| Shahid Beheshti University of Medical Sciences | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CENTESSA PHARMACEUTICALS PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
